The metabolic and cardiovascular clinical manifestations in patients with Cushing's syndrome
(CS) are generally well known. However, recent studies have broadened the perspective …

Glucocorticoids are powerful modulators of brain function. They act via mineralocorticoid and
glucocorticoid receptors (MR and GR). These are best understood as transcription factors. …

Pituitary adenomas (PA) are typically benign, slow-growing tumors of the adenohypophysis,
which come to attention because of associated endocrine dysfunction (eg, …

Background The extent to which people implement government-issued protective measures
is critical in preventing further spread of coronavirus disease 2019 (COVID-19) caused by …

Objective To test the hypothesis that systemic and inhaled glucocorticoid use is associated
with changes in grey matter volume (GMV) and white matter microstructure. Design Cross-…

Context Insight into the current landscape of patient-reported outcome (PRO) measures (PROM)
and differences between PROs and conventional biochemical outcomes is pivotal for …

Synthetic glucocorticoids are clinically used to treat auto-immune and inflammatory disease.
Despite the high efficacy, glucocorticoid treatments causes side effects such as obesity and …

Background Synthetic glucocorticoids are widely used among patients suffering from a wide
range of diseases. Glucocorticoids are very efficacious, but can be accompanied by …

Objective The European Reference Network on Rare Endocrine Conditions (Endo-ERN)
aims to organize high-quality healthcare throughout Europe, including care for pituitary …

Background Pituitary adenomas can give rise to a variety of clinical disorders and surgery is
often the primary treatment option. However, preoperative magnetic resonance imaging (…